Trial intelligence / Profile preview

Glyceroltrinitrate effect on BAT thermogenesis

NCT05711199Phase 1Completed

Sponsor
University Hospital Basel
Start
Mar 2023
Primary completion
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of nitroglycerin in obesity (2 arms), sponsored by University Hospital Basel. Primary endpoints: Brown Adipose Tissue Standardized Uptake Value mean at 14 days and Brown Adipose Tissue Standardized Uptake Value max at 14 days. Started Mar 2023; status: completed.

02

Drugs

nitroglycerin
03

Conditions

obesity

Beyond the preview

Go deeper on NCT05711199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05711199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call